Promise Details
Kennedy pledged to lead a federal effort to study the biological causes of autism and expand clinical trials on leucovorin, a compound used to address folate receptor autoantibodies in some children. He claimed this could revolutionize treatment and diagnosis. Yet, no new large-scale trials were funded, and NIH pilot programs were quietly cancelled due to lack of evidence and ethical concerns. Medical experts criticized the initiative for diverting research money without results.
Why it is broken
Despite bold campaign promises, the administration failed to fund major autism-cause investigations or expand leucovorin trials. NIH canceled planned studies citing lack of clinical evidence and ethical challenges. Advocacy groups expressed frustration over redirected funds and limited transparency in research decisions. Medical experts criticized Kennedy’s approach as politicized rather than scientific. The initiative ended with no measurable progress, rendering the promise broken.
Sources
The information presented in this promise is aggregated from various publicly available sources. We do not claim ownership or guarantee the accuracy of the content. All data is collected and cross-validated from multiple independent sources. To read more about this promise, please view the source links below:
Support Our Work
Help us keep the website running and free for everyone by supporting us:
